The numbers coming out of Almonty Industries’ Sangdong tungsten mine are, on paper, exactly what shareholders have waited years to see. The South Korean asset began processing stockpiled material through its newly commissioned plant in June, producing saleable concentrate for the first time. Two weeks later, the company expanded its long-term offtake contract with Global Tungsten & Powders from 15 to 21 years, hiking the committed volume by 40% to 4.41 million MTU — a deal the miner values at roughly $490 million in annual revenue at current APT prices and one that extends well into the 2040s.
Yet the stock closed Thursday at 18.52 Canadian dollars, down 5.89% on the day alone. Over the past week, the decline totals 20.79%, and the monthly slide stands at 28.27%. The shares now trade 44.47% below their 52-week high of C$33.35, reached in April. The disconnect between operational progress and market performance has rarely been wider.
Production Reality Versus the Capital-Market Headwind
Sangdong’s transition from construction to commercial operation this summer marks the end of a long development phase for Almonty, a junior tungsten producer positioning itself as a key non-Chinese source of the strategic metal. The expanded GTP offtake now covers roughly 90% of the mine’s planned Phase I concentrate output. Founder and CEO Lewis Black described the terms as a reflection of “what Sangdong’s conflict-free tungsten is worth in today’s market,” noting that China’s export restrictions have kept prices elevated. The agreement does not yet include the Phase II expansion, which would nearly double annual processing capacity — meaning the current revenue visibility understates the mine’s eventual potential.
But the market is ignoring the long-term contract visibility. Instead, attention is fixed on a trio of pressures that have overwhelmed the operational narrative.
Dilution, Insider Sales, and a Widening Loss
The number of outstanding Almonty shares has surged 49.9% over the past twelve months, largely driven by the placement of a large convertible debenture intended to fund the mine’s scale-up. That financing coincided with the stock’s slide from its April peak, and analysts view it as inherently dilutive. The impact on per-share value is being felt acutely: for fiscal 2025, Almonty reported a net loss of C$161.9 million, or C$0.78 per share, compared with a loss of C$0.096 per share a year earlier. Revenue rose 13% to C$32.5 million but missed analyst estimates by 12%.
Adding to the overhang, insider selling has accelerated. A director sold 200,000 common shares on July 2 at US$24.07 apiece, a transaction worth US$4.814 million that trimmed his stake by 7.4%. Across the past twelve months, net insider sales total US$6.4 million, with the bulk concentrated in the last three months. Those disposals send a signal that unnerves retail holders, even if company insiders may have personal liquidity needs unrelated to the business outlook.
Should investors sell immediately? Or is it worth buying Almonty?
The stock’s 30-day annualized volatility stands at 102.66%, a figure that suggests the market has yet to form a settled view on how to weigh execution risk against contractual revenue certainty. The relative strength index at 35 puts the shares just above oversold territory — a level that can either precede a bounce or stall as selling pressure persists without a clear catalyst for reversal.
Bulls See a Floor, Bears Point to the Ramp-Up Risk
For optimists, the 21-year offtake agreement provides a degree of revenue visibility almost unheard of among junior producers. The pricing was negotiated during a period of historically high tungsten prices, and the contract establishes a base-load revenue stream that, assuming stable ore grades and APT prices, implies a valuation floor. The stock still trades nearly 200% above its level twelve months ago, and inclusion in the Russell 1000 and Russell 3000 indexes broadens the potential investor base.
But the bear case revolves around whether Sangdong can actually deliver the contracted volumes and grades. The processing plant is currently handling lower-grade stockpiled material; higher-grade ore is expected only in later production phases. Almonty itself lists future APT pricing, actual delivery volumes, and the Phase II expansion as open variables. On the balance sheet, the convertible debenture introduces leverage that will test net debt and interest coverage ratios as the ramp-up proceeds.
Technically, the stock is trading 25.37% below its 50-day moving average of C$24.80 and only a whisker above the 200-day average of C$18.92. A break below that level would open the door to further declines. A recovery above the 200-day, by contrast, could confirm that the monthly retreat — steep as it is — represents a correction tied to dilution and profit-taking rather than a reversal of the underlying growth narrative.
The next meaningful signals will come from operational updates on throughput and ore grade at Sangdong, along with disclosures on insider transactions and how the company intends to manage the convertible debt’s dilutive impact. Until those numbers show whether contractual commitments are turning into delivered output, the stock may remain caught between a mine that is finally producing and a market that is still pricing in the risk that it won’t produce enough.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from July 17 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 17.
Almonty: Buy or sell? Read more here...
